P401 Risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications: Reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study
P401 炎症性肠病药物与严重 COVID-19 后果风险相关：来自英国 PREPARE-IBD 多中心队列研究的令人安心的见解
期刊:World Journal of Gastrointestinal Endoscopy
影响因子:1.8
doi:10.4253/wjge.v6.i5.200
Navaneethan, Udayakumar; Konjeti, Rajesh; Venkatesh, Preethi Gk; Sanaka, Madhusudhan R; Parsi, Mansour A; Lamb, C A; Sebastian, S; Kent, A J; Segal, J P; Gonzalez, H A; Brookes, M J; Mehta, S J; Subramanian, S; Bhala, N; Hicks, L C; Conley, T E; Patel, K V; Walker, G J; Kennedy, N A
